MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-20-0005485
Innovative Pharmaceuticals Private Limited - pharma in Nagpur, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹45.31 Cr
▼ 15% YoY
Net profit · FY 2024
₹6.84 Cr
Net margin 15.1%
EBITDA · FY 2024
₹9.85 Cr
EBITDA margin 21.7%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹10.2 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Employees · EPFO
71
Provident fund records
About Innovative Pharmaceuticals Private Limited
Data last updated:
Innovative Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2020PTC341837. Its GSTIN is 27AAFCI6981C1ZF (Maharashtra).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors Mahesh Chandrabhan Kingrani and Rajesh Kingrani Chandrabhan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No.6 Harinwar Layout Ward No.1 Near Axis Bank Wadi, Nagpur, Maharashtra, India – 440023.
As per the financials filed for FY 2024, the company reported a revenue of ₹45.31 Cr, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹6.84 Cr (net margin 15.1%) and EBITDA of ₹9.85 Cr (EBITDA margin 21.7%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years.
The company has about 71 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹10.2 Cr on record. Court records list 65 cases involving the company, including 59 filed by the company and 6 filed against it; 40 cases are pending. The company has 1 deal on record (1 secondary share transfer); the latest was in December 2021. Its 3 peer companies in the FMCG industry (Personal Care and Skin Care, Pharmaceuticals), with the same principal business activity (wholesale trading) are compared by revenue, 3 smaller; the largest is Xtracare Products Private Limited with revenue of ₹45.28 Cr.
Innovative Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-20-0005485). For more details, the company can be reached via its website innovativepharma.in.
Company details
CIN U24230MH2020PTC341837
Registration Number 341837
Incorporation Date 13 July 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Medium
Udyam Registration UDYAM-MH-20-0005485
Recognitions & Rankings of Innovative Pharmaceuticals
Contact details
Innovative Pharmaceuticals Private Limited's registered office is in Nagpur, Maharashtra. Its website is innovativepharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No.6 Harinwar Layout Ward No.1 Near Axis Bank Wadi, Nagpur, Maharashtra, India – 440023
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Innovative Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Innovative Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Innovative Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Innovative Pharmaceuticals Private Limited, buy the company report.
Financials of Innovative Pharmaceuticals Private Limited
FY 2024 filings availableInnovative Pharmaceuticals Private Limited reported revenue of ₹45.31 Cr (down 15% YoY) for FY 2024.
Revenue · FY 2024
₹45.31 Cr ▼ 15%
Net profit · FY 2024
₹6.84 Cr margin 15.1%
EBITDA · FY 2024
₹9.85 Cr margin 21.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 15%
3 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▼ 22%
3 years · compounded
▲ 1%
Revenue fell 15% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 7%. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹9.85 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹6.84 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 21.7% | |||
| Net Profit Margin | 15.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Innovative Pharmaceuticals Private Limited, buy the company report.
Board of directors of Innovative Pharmaceuticals Private Limited
Innovative Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahesh Chandrabhan Kingrani | Director | 13 Jul 2020 | 6 Years 3 Months | Current |
| Rajesh Kingrani Chandrabhan | Director | 13 Jul 2020 | 6 Years 3 Months | Current |
Peer comparison
Innovative Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the FMCG industry (Personal Care and Skin Care, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Innovative Pharmaceuticals Private Limitedthis company | ₹45.31 Cr (FY 2024) | ₹6.84 Cr | 15.1% | -15.0% | 71 | Nagpur, Maharashtra, India |
| Xtracare Products Private Limited | ₹45.28 Cr (FY 2025) | -35.0% | Bhubaneswar, Odisha, India | |||
| Dipika Pharmaceuticals Private Limited | ₹44.84 Cr (FY 2024) | 8.0% | Kolkata, West Bengal, India | |||
| Sharaya Cosmocare Private Limited | ₹44.52 Cr (FY 2025) | 25.0% | Delhi, India |
To see the full peer comparison of Innovative Pharmaceuticals Private Limited, buy the company report.
Auditor
Innovative Pharmaceuticals Private Limited is audited by R.A.DASWANI & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R.A.DASWANI & CO. | FY 2023 | 128981W |
Shareholding
The shareholding of Innovative Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Innovative Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹10.2 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Jul 2025 | 101144150 | Others | ₹9.85 Cr | Open | |
| 05 Nov 2024 | 101002945 | Hdfc Bank Limited | ₹35 Lakh | Open |
Total charge records: 2 View all charges
Deals & funding
Innovative Pharmaceuticals Private Limited has 1 deal on record (1 secondary share transfer); the latest was in December 2021.
Total deals
1
Secondary share transfer
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2021 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Innovative Pharmaceuticals Private Limited has 65 court cases on record: 59 filed by Innovative Pharmaceuticals, 6 filed against it. 40 cases are pending and 25 are disposed.
Total cases
65
Filed by the company
59
Filed against the company
6
Pending
40
Disposed
25
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 64 | 6 | 39 |
| High courts | 1 | 0 | 1 |
Cases on record (5 of 65)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Civil suit | Filed against the company by Bajaj Healthcare Ltd. | Pending |
| District court, Nagpur, Maharashtra | Civil suit | Filed by the company against Pink Revolution India Pvt Ltd, Rewari and 2 others | Disposed |
| District court, Nagpur, Maharashtra | Civil suit | Filed by the company against Jayadeva Pharmacy, Ameerpet | Pending |
| District court, Nagpur, Maharashtra | Civil suit | Filed by the company against Vimal Pharma Davangere | Pending |
| District court, Nagpur, Maharashtra | Civil suit | Filed by the company against V.M. Enterprises, Ratlam and 1 other | Pending |
To see the full case history of Innovative Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Innovative Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Innovative Pharmaceuticals Private Limited has a workforce of 71 employees on its EPFO records as of Mar 30, 2024, across 1 active EPFO establishment.
Employee count
71
Active EPFO establishments
1
Employee growth
20.34%
GST
Innovative Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCI6981C1ZF | Maharashtra | Active | 27 Jul 2020 |
To see the full GST registrations and return filing status of Innovative Pharmaceuticals Private Limited, buy the company report.
Recent activity
Innovative Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Mahesh Chandrabhan Kingrani was appointed as Director on 13 Jul 2020.
Charges
A charge with Others amounted to Rs. 9.85 Cr with Charge ID 101144150 was registered on 31 Jul 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.35 Cr with Charge ID 101002945 was registered on 05 Nov 2024.
AGM
Innovative Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Innovative Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Appointed
Mahesh Chandrabhan Kingrani was appointed as Director.
Appointed
Rajesh Kingrani Chandrabhan was appointed as Director.
Incorporation
13 Jul 2020
Innovative Pharmaceuticals Private Limited was registered on 13 Jul 2020 with Roc Mumbai & aged 6 years 3 months as per MCA records.
Frequently asked questions
Innovative Pharmaceuticals is an active private limited company based in Nagpur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 July 2020 (6+ years old) and is registered under CIN U24230MH2020PTC341837.
Innovative Pharmaceuticals has 2 current directors:
- Mahesh Chandrabhan Kingrani - Director
- Rajesh Kingrani Chandrabhan - Director
The latest financial statements of Innovative Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Innovative Pharmaceuticals is 27AAFCI6981C1ZF, registered in Maharashtra.
The CIN (Corporate Identification Number) of Innovative Pharmaceuticals is U24230MH2020PTC341837. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Innovative Pharmaceuticals has 65 court cases on record: 59 filed by the company and 6 filed against it. 40 are pending. Most are in the district courts.
Innovative Pharmaceuticals was incorporated on 13 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Innovative Pharmaceuticals has 1 deal on record (1 secondary share transfer); the latest was in December 2021.
The peers of Innovative Pharmaceuticals by revenue are Xtracare Products Private Limited, Dipika Pharmaceuticals Private Limited, Sharaya Cosmocare Private Limited, all in the FMCG industry (Personal Care and Skin Care, Pharmaceuticals), with the same principal business activity (wholesale trading).
Mahesh Chandrabhan Kingrani was appointed as Director on 13 Jul 2020. Rajesh Kingrani Chandrabhan was appointed as Director on 13 Jul 2020.
Yes, Innovative Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-20-0005485).